6/24/2022  9:59:58 PM Chg. +0.17 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
30.00USD +0.57% 55,553
Turnover: 1.66 mill.
-Bid Size: - -Ask Size: - 1.31 bill.USD 0.00% 27.78

Business description

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products and diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral and respiratory infections. Meridian’s diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents, specialty biologicals and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products and technologies to hospitals, reference laboratories, research centers, diagnostics manufacturers and biotech companies in more than 70 countries around the world. The Company’s shares are traded on NASDAQ’s Global Select Market, symbol VIVO.
 

Management board & Supervisory board

CEO
Jack P. Kenny
Management board
Bryan T. Baldasare, Charles Wood, Lourdes G. Weltzien, Melissa McCarey, Tony Serafini-Lamanna
Supervisory board
David C. Philips, Anthony P. Bihl, III, Catherine A. Sazdanoff, Dwight E. Ellingwood, Felicia Williams, Jack P. Kenny, James M. Anderson, John C. McIlwraith, John M. Rice
 

Company data

Name: Meridian Bioscience Inc.
Address: 3471 River Hills Drive,Cincinnati, Ohio 45244, USA
Phone: +1-513-271-3700
Fax: +1-513-271-3762
E-mail: mbi@meridianbioscience.com
Internet: www.meridianbioscience.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 9/30
Free Float: 59.96%
IPO date: 1/1/1986

Investor relations

Name: Jack P. Kenny
IR phone: -
IR Fax: -
IR e-mail: -

Main Shareholders

Freefloat
 
59.96%
BlackRock, Inc.
 
16.10%
The Vanguard Group, Inc.
 
10.74%
Renaissance Technologies LLC
 
7.67%
Deerfield Mgmt, L.P.
 
5.53%